Janney Montgomery Scott LLC Raises Holdings in Zynex, Inc. (NASDAQ:ZYXI)

Janney Montgomery Scott LLC increased its holdings in shares of Zynex, Inc. (NASDAQ:ZYXI) by 10.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 159,259 shares of the company’s stock after acquiring an additional 14,820 shares during the quarter. Janney Montgomery Scott LLC owned about 0.50% of Zynex worth $1,276,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC raised its position in shares of Zynex by 24.7% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 746,380 shares of the company’s stock valued at $6,090,000 after buying an additional 147,770 shares during the period. Millennium Management LLC lifted its holdings in shares of Zynex by 66.5% in the 2nd quarter. Millennium Management LLC now owns 297,082 shares of the company’s stock worth $2,769,000 after acquiring an additional 118,615 shares during the last quarter. GSA Capital Partners LLP boosted its position in shares of Zynex by 72.7% during the 3rd quarter. GSA Capital Partners LLP now owns 79,930 shares of the company’s stock worth $652,000 after purchasing an additional 33,649 shares during the period. Geode Capital Management LLC increased its holdings in Zynex by 6.7% in the 3rd quarter. Geode Capital Management LLC now owns 425,509 shares of the company’s stock valued at $3,473,000 after purchasing an additional 26,774 shares during the last quarter. Finally, Royce & Associates LP raised its position in Zynex by 9.2% in the third quarter. Royce & Associates LP now owns 257,291 shares of the company’s stock valued at $2,099,000 after purchasing an additional 21,781 shares during the period. 29.68% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Zynex

In other news, CFO Daniel J. Moorhead sold 10,000 shares of Zynex stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $7.68, for a total value of $76,800.00. Following the completion of the sale, the chief financial officer now owns 19,738 shares of the company’s stock, valued at $151,587.84. The trade was a 33.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 36,000 shares of company stock valued at $288,860 in the last ninety days. 52.13% of the stock is currently owned by company insiders.

Zynex Price Performance

Zynex stock opened at $8.06 on Wednesday. The company has a debt-to-equity ratio of 1.66, a current ratio of 3.94 and a quick ratio of 3.15. The business has a 50 day simple moving average of $8.10 and a 200-day simple moving average of $8.18. Zynex, Inc. has a 12 month low of $7.15 and a 12 month high of $13.77. The stock has a market capitalization of $256.68 million, a PE ratio of 53.73 and a beta of 0.53.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ZYXI. HC Wainwright reaffirmed a “buy” rating and set a $17.00 target price on shares of Zynex in a research note on Friday, December 6th. Royal Bank of Canada cut their price objective on Zynex from $12.00 to $11.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th.

About Zynex

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.